What You Should Know: - Prenosis, Inc., a precision medicine company, announced a venture investment from PACE Healthcare Capital, an early-stage investment firm committed to improving health outcomes. This investment brings total funding in the company to over $20 million, including partnerships with Foxconn, Roche Diagnostics, the Defense Threat Reduction Agency, and others. - Precision medicine company will use the funding to
Read More
Personalized Medicine | Digital Health | News, Analysis, Insights - HIT Consultant
Crisis in the U.S. Healthcare Workforce: Why It’s Time to introduce AI
One of the many acute challenges during the pandemic has been the departure of approximately 18% of the U.S. healthcare workforce,4 resulting in staffing shortages in hospitals. This has impacted the well-being of the remaining healthcare practitioners 5 as well as their patients – many of whom are deferring care that is vital to disease management and overall maintenance of health,6,7 or who do not have access to timely emergency care.1 Though such challenges may be perceived as insurmountable
Read More
Variantyx Secures $41.5M for Genetic Testing and Personalized Medicine
What You Should Know: - Variantyx, a technology-driven precision medicine company providing advanced genomic testing for the rare genetic disorders, reproductive health, and precision oncology markets, today announced they have secured $41.5M in C-2 funding led by New Era Capital Partners and includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners, and Pitango HealthTech. - Founded in 2014, the Variantyx proprietary whole genome sequencing and analysis
Read More
Genetika+ Raises $10M for Personalized Medicine for Psychiatry Solution
What You Should Know: - Genetika+, a female-founded startup focused on developing personalized medicine for psychiatry conditions, that the company has closed a $10 million Series A round led by GreyBird Ventures with participation from Meron Capital, Jumpspeed Ventures, Sapir Venture Partners, Howard Morgan Chairman of B Capital Group and Michael Zeisser of FMZ Ventures and former Chairman, Investments at Alibaba Group. - Founded in 2018 by Talia Cohen-Solal, Ph.D., and Daphna
Read More
From Analog to Digital Neurology: 3 Steps to Better Inform Patient Care
The field of neurology is at an inflection point. With a growing aging population, neurologists are facing an increasing number of patients needing care, and the pent-up demand for services due to COVID-19 only exacerbates this issue. The pressure on neurologists is enormous, with surveys indicating excessive stress caused by inefficient workflow and mounting paperwork 1,2. It is becoming increasingly clear that the traditional analog neurological exam and referral system is overwhelmed, and
Read More
Patient-First Model: High Tech Meets High Touch for Individuals with Rare Disorders
Industry experts state that orphan drugs will be a major trend to watch in the years ahead, accounting for almost 40% of the Food and Drug Administration approvals this year. This market has become more competitive in the past few years, increasing the potential for reduced costs and broader patient accessibility. Currently, these products are often expensive because they target specific conditions and cost on average $147,000 or more per year, making commercialization
Read More
NIH Taps PhysIQ to Develop AI-Based COVID-19 Digital Biomarker
What You Should Know: - physIQ has been selected by the National Institute of Health (NIH) to develop an innovative AI-based COVID-19 digital biomarker solution to address the COVID-19 pandemic. - Early detection of COVID-19 decompensation in patients
is complicated by infrequent and non-specific clinical data. The first-in-kind
tool will collect and analyzes continuous physiologic data could provide early
clinical indicators of COVID-19 decompensation. The National Cancer
Institute
Read More
Anthem, Apple Launches 2-Year Digital Asthma Study with Apple Watch
What You Should Know: - Anthem, Inc. announced a new study that examines how
the use of everyday devices, like Apple Watch and iPhone, may help individuals
with asthma, led by the University of California, Irvine. - Launching in the fall, the two-year, randomized controlled
study will enroll participants from Anthem-affiliated health plans who have
been clinically diagnosed with asthma. -Anthem, Inc. today a new study that examines how the use of everyday devices, like Apple Watch
Read More
Analysis: August Health IT M&A Activity; Public Company Performance
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of August 2020. M&A is back and the velocity of the rebound has outpaced all expectations. The recovery quickly worked its way across the spectrum from large to small-cap, beginning with the larger cap NASDAQ rally of nearly 80% from lows in late March (only to soften in recent days), followed by multi-billion
Read More
Fitbit Launches Ready for Work Program to Help Employers Manage Workplace Health During COVID-19
What You Should Know: - Fitbit launches new Ready for Work program to help
organizations with the unprecedented challenge of returning to the workplace
during the COVID-19 health crisis. - The program combines key health biometrics from Fitbit devices along with symptom and temperature tracking into an easy-to-use daily check-in that provides employees with a recommendation on whether to go to work or stay home and seek medical care. - Early research shows that resting heart rate data
Read More
